The global direct-to-consumer genetic testing market is experiencing a surge in popularity, driven by technological advancements and growing consumer interest in personal health. According to Future Market Insights, the market is poised to grow from its projected value of US$1,645.5 million in 2023 to an astounding US$4,843.4 million by the year 2033, representing a remarkable Compound Annual Growth Rate (CAGR) of 11.4%.
Without the need of a healthcare professional middleman, direct-to-consumer (DTC) genetic testing allows anyone to obtain genetic information about their heritage, physical characteristics, and possible illness risks straight from commercial genetic testing companies. These tests use cheek swab or saliva samples to evaluate a person’s DNA and reveal information about their background, genetic predispositions, and overall wellness.
Refine Strategies: Request Your Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15137
There are multiple reasons for the expected expansion of the worldwide direct-to-consumer genetic testing industry. Genetic testing is becoming more widely available and easier for consumers to use thanks to developments in data analytics and DNA sequencing technologies as well as the growing affordability of genetic testing kits. The need for genetic insights to guide lifestyle decisions, disease preventive tactics, and healthcare decisions is also being driven by growing consumer awareness of the value of proactive health management and personalized treatment.
Competitive Landscape:
Some of the prominent players in the global market are-
- 23andMe
- Ancestry DNA
- Color Genomics, Inc.
- Genetic Technology (EasyDNA)
- Full Genomes Corporation, Inc.
- Helix OpCo LLC
- IDENTIGENE, LLC/ DNA Diagnostics Center
- Living DNA Ltd
- MyHeritage Ltd
- Prenetics Limited
- Family Tree DNA
- Interleukin Genetics/orig3n
- Counsyl/Myriad Genetics, Inc.
- Veritas Genetics
- Fulgent Genomics
Some of the recent industry developments in the global direct-to-consumer genetic testing market are:
- In January 2022, 23andMe Holding Co., a leading consumer genetics and research company, received FDA clearance for a genetic health risk report on a hereditary prostate cancer marker.
- In August 2021, Ancestry, a global leader in family history, announced that it has agreed to acquire Geneanet, a renowned French genealogy company. With over 30 billion records from more than 80 countries, Ancestry helps customers discover new details about their family stories and ancestors.
- In June 2023, Prenetics Global Limited, a leading genomics and precision oncology company, announced financial results for the first quarter ending March 31, 2023, along with recent business updates.
Obtain Methodology Information:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15137
Direct-to-Consumer Genetic Testing Market Outlook by Category
By Product:
- Pharmacogenetics Tests
- Carrier Screening Tests
- Genetic Health Risk (GHR) Tests
- Cancer Predisposition Tests
- Low-Risk General Wellness Tests
- Ancestry Tests
By Technology:
- Single Nucleotide Polymorphism Chip
- Whole Genome Sequencing
By Sample:
- Saliva
- Urine
- Blood
By Sales Channel:
- Institutional Sales
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Others
- Retail Sales
- Retail Pharmacies
- Online Sales
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- Middle East and Africa
Gain to Comprehensive Market Analysis: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/15137
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
